Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Relief Therapeutics, NeuroRx File IND for Aviptadil for COVID-19-Induced Respiratory Distress

americanpharmaceuticalreviewApril 01, 2020

Tag: Relief Therapeutics , Aviptadil , COVID-19 , NeuroRx

PharmaSources Customer Service